|
国家基本药物(化药部分)风险管理平台的建立 |
The Establishment of Risk Management System for National Essential Drugs |
投稿时间:2011-11-09 修订日期:2012-01-15 |
DOI: |
中文关键词: 基本药物 药物安全 风险管理 风险评估 |
英文关键词:Essential drugs Drug safety Risk management Risk evaluation |
基金项目: |
|
摘要点击次数: 1404 |
全文下载次数: 2183 |
中文摘要: |
摘 要 目的:全面总结分析国家基本药物说明书、不良反应报告和文献信息,建立药物风险管理平台,实现药物风险评估,为群众安全用药提供参考依据。方法:文献调研,信息收集整理,数据比较,统计计算,网络平台搭建。结果:收集并分析国家基本药物原研厂最新英文说明书、中文说明书、不良反应报告和文献等信息,开发国家基本药物风险管理平台。结论:国家基本药物风险管理平台提供了药物说明书差异性的比较、药物安全信息检索和药物风险评估等功能,为群众用药安全提供帮助。 |
英文摘要: |
ABSTRACT Objective: To establish the drug risk management system to realize the evaluation of drug risk and also provide a reference for safe medication by fully concluding and analyzing drug instructions, adverse drug reaction reports and literatures of national essential drugs.Method:Literatures were investigated and collected; drugs’ information were processed; their data were compared; drugs’ ADR ratio was counted and calculated; and a Web platform was constructed.Result: The latest version instructions of national essential drugs, including English and Chinese drug instructions, ADR reports and literatures, were gathered and analyzed. A valuating method for drug safety was created and the risk management system of national essential drugs (RMSNED) was established.Conclusion:The RMSNED provided such functions as the comparison of drug instructions, retrieval of drugs’ safety information and evaluation of drugs risk for the safe medication assistance. |
查看全文 查看/发表评论 下载PDF阅读器 |
关闭 |